# HSG Holding Ltd: Form 13F holdings

An institutional investment manager in NA. SEC CIK 1470766.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $1.24bn
- Positions: 20 (27 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1470766/000119312526348168/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [PDD HOLDINGS INC (PDD)](/companies/pdd.md) | SPONSORED ADS | $865.7m | 72.3% | 11,348,426 |  | Unchanged |
| [FUTU HLDGS LTD (FUTU)](/companies/futu.md) | SPON ADS CL A | $69.4m | 5.8% | 740,352 |  | Unchanged |
| [PONY AI INC (PONY)](/companies/pony.md) | SPONSORED ADS | $52.4m | 4.4% | 7,538,358 |  | Unchanged |
| [CIRCLE INTERNET GROUP INC (CRCL)](/companies/crcl.md) | COM CL A | $41.9m | 3.5% | 669,200 |  | Unchanged |
| [KE HLDGS INC (BEKE)](/companies/beke.md) | SPONSORED ADS | $28.2m | 2.4% | 1,939,017 |  | Unchanged |
| [GYRE THERAPEUTICS INC (GYRE)](/companies/gyre.md) | COM | $24.7m | 2.1% | 3,750,299 |  | New +3,750,299 |
| [KANZHUN LIMITED (BZ)](/companies/bz.md) | SPONSORED ADS | $24.5m | 2.0% | 1,900,000 |  | Unchanged |
| [ARRIVENT BIOPHARMA INC (AVBP)](/companies/avbp.md) | COM | $23.0m | 1.9% | 663,308 |  | Unchanged |
| [DINGDONG CAYMAN LTD (DDL)](/companies/ddl.md) | ADS | $19.5m | 1.6% | 10,091,839 |  | Unchanged |
| [STRUCTURE THERAPEUTICS INC (GPCR)](/companies/gpcr.md) | SPONSORED ADS | $14.3m | 1.2% | 266,062 |  | Unchanged |
| [51TALK ONLINE EDUCATION GROU (COE)](/companies/coe.md) | SPONSORED ADR | $7.6m | 0.6% | 474,901 |  | Unchanged |
| [LOTUS TECHNOLOGY INC (LOT)](/companies/lot.md) | SPONSORED ADR | $5.7m | 0.5% | 4,834,099 |  | Unchanged |
| [ADAGENE INC (ADAG)](/companies/adag.md) | ADS | $5.6m | 0.5% | 1,343,364 |  | Unchanged |
| TH INTERNATIONAL LIMITED | SHS NEW | $5.5m | 0.5% | 2,900,606 |  | Unchanged |
| BITDEER TECHNOLOGIES GROUP | CL A ORD SHS | $4.7m | 0.4% | 293,732 |  | Unchanged |
| [LYELL IMMUNOPHARMA INC (LYEL)](/companies/lyel.md) | COM NEW | $2.1m | 0.2% | 152,299 |  | Unchanged |
| SOLAI LIMITED | SPON ADR | $1.1m | <0.1% | 350,427 |  | Unchanged |
| BARINTHUS BIOTHERAPEUTICS PL | ADS | $937.5k | <0.1% | 1,420,473 |  | Unchanged |
| [BURNING ROCK BIOTECH LTD (BNR)](/companies/bnr.md) | SPONSORED ADS | $177.5k | <0.1% | 21,212 |  | Unchanged |
| YIMUTIAN INC | SPONSORED ADS | $121.6k | <0.1% | 229,470 |  | New +229,470 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| WEBULL CORP | ORD SHS | $0 | 0.0% | 0 |  | Sold out −7,053,639 |
| YIMUTIAN INC | SPONSORED ADS | $0 | 0.0% | 0 |  | Sold out −3,442,060 |

Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-348168. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.